Director Fred E. Cohen resigns from UroGen Pharma board effective immediately

UroGen Pharma Ltd.

Fred E. Cohen resigned as director on Sept 12, 2024.
Resignation is not due to any disagreement with the company.
No replacement director has been announced.
Dr. Cohen's departure is effective immediately.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Fred E. Cohen

Director

URGN · UroGen Pharma Ltd.

Effective: 2024-09-12
Filed: September 13, 2024, 7:59 PM ET

On September 12, 2024, Fred E. Cohen, M.D., D.Phil., notified UroGen Pharma Ltd. (the “Company”) of his resignation as a director of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Fred E. Cohen resigned as Director at UroGen Pharma Ltd..

Action: resigned
Role: Director

Exact text from the filing

On September 12, 2024, Fred E. Cohen, M.D., D.Phil., notified UroGen Pharma Ltd. (the “Company”) of his resignation as a director of the Company, effective immediately.

View on SEC.gov

UroGen Pharma Ltd. filing history →

Source: SEC EDGAR

accession 0001193125-24-218868

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.